Fifth Third Bancorp’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Fifth Third Bancorp’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-91	Closed	-$12K	–	2665
2025 Q1	$12K	Buy	91 +81	+810%	+$10.1K	﹤0.01%	1938
2024 Q4	$835	Hold	10	–	–	﹤0.01%	2421
2024 Q3	$732	Buy	+10	New	+$752	﹤0.01%	2479
2021 Q3	–	Sell	-3,233	Closed	-$132K	–	2775
2021 Q2	$132K	Buy	+3,233	New	+$120K	﹤0.01%	1102
2020 Q4	–	Sell	-600	Closed	-$15K	–	2474
2020 Q3	$15K	Hold	600	–	–	﹤0.01%	1665
2020 Q2	$15K	Buy	+600	New	+$12.1K	﹤0.01%	1639

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fifth Third Bancorp's ITCI Position: Q2 2025 in Review

Fifth Third Bancorp sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 91 shares — an estimated $12K sold.

Fifth Third Bancorp first reported a position in ITCI in Q2 2020 and held it in 6 quarters. The position peaked at $132K in Q2 2021. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Fifth Third Bancorp reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Fifth Third Bancorp sold 91 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $12K.
Fifth Third Bancorp first reported a position in Intra-Cellular Therapies Inc. in Q2 2020 and held it in 6 quarters.
Fifth Third Bancorp's Intra-Cellular Therapies Inc. position peaked at $132K in Q2 2021.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Fifth Third Bancorp's 13F filing for Q2 2025, filed 15 Jul 2025.